# Systematic review with meta‐analysis: the efficacy and safety of CT‐P13, a biosimilar of anti‐tumour necrosis factor‐α agent (infliximab), in inflammatory bowel diseases

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/systematic-review-with-meta-analysis-the-efficacy-and-safety-of-ct-p13-a/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yuga Komaki,Akihiro Yamada,Fukiko Komaki,Dejan Micić,A. Ido,Atsushi Sakuraba |
| Citations | 105 |
| DOI | 10.1111/apt.13990 |
| Fields | Biochemistry, Genetics and Molecular Biology,Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/apt.13990 |
| OpenAlex ID | https://openalex.org/W2589358629 |
| PMID | 28239873 |
| Type | review |
| Year | 2017 |

## Paper authors

- [Dejan Micić](https://scholariq.org/researchers/dejan-micic/)

## Paper journal

- [Alimentary Pharmacology & Therapeutics](https://scholariq.org/journals/alimentary-pharmacology-and-therapeutics/)

## Paper primary topic

- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)

## Paper topics

- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)
- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Microscopic Colitis](https://scholariq.org/topics/microscopic-colitis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.